{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:10:36Z","timestamp":1770675036455,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1136\/ard.2008.095315","type":"journal-article","created":{"date-parts":[[2009,10,12]],"date-time":"2009-10-12T17:44:49Z","timestamp":1255369489000},"page":"1659-1665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Musculoskeletal manifestations of lysosomal storage disorders"],"prefix":"10.1016","volume":"68","author":[{"given":"M","family":"Aldenhoven","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R J B","family":"Sakkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Boelens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T J","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N M","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2008.095315_bib1","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1651-2227.2005.tb02004.x","article-title":"Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I","volume":"94","author":"Vijay","year":"2005","journal-title":"Acta Paediatr"},{"key":"10.1136\/ard.2008.095315_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.bor.0000147283.40529.13","article-title":"Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I)","volume":"17","author":"Pastores","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.2008.095315_bib3","first-page":"196","article-title":"Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome","volume":"24","author":"Cimaz","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2008.095315_bib4","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s10067-007-0549-6","article-title":"Legg-Perthes disease-like joint involvement and diagnosis delay in Scheie syndrome: a case report","volume":"26","author":"Melikoglu","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2008.095315_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10067-006-0299-x","article-title":"Rheumatologic aspects of lysosomal storage diseases","volume":"26","author":"Manger","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2008.095315_bib6","first-page":"188","article-title":"Fellow clinical challenge","volume":"1","author":"Wagner","year":"2003","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1136\/ard.2008.095315_bib7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/BF02283120","article-title":"Joint manifestations of Fabry\u2019s disease","volume":"11","author":"Paira","year":"1992","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2008.095315_bib8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/art.1780250616","article-title":"Interphalangeal joint involvement in Gaucher\u2019s disease, type I, resembling juvenile rheumatoid arthritis","volume":"25","author":"Weizman","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.095315_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1136\/ard.2008.095315_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum Genet"},{"key":"10.1136\/ard.2008.095315_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF02396619","article-title":"Radiological findings in patients with mucopolysaccharidosis I H\/S (Hurler-Scheie syndrome)","volume":"17","author":"Schmidt","year":"1987","journal-title":"Pediatr Radiol"},{"key":"10.1136\/ard.2008.095315_bib12","first-page":"178","article-title":"Bony changes in common mucopolysaccharidoses","volume":"37","author":"Chen","year":"1996","journal-title":"Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi"},{"key":"10.1136\/ard.2008.095315_bib13","series-title":"The metabolic and molecular basis of inherited disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1136\/ard.2008.095315_bib14","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J Pediatr"},{"key":"10.1136\/ard.2008.095315_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00003086-197410000-00020","article-title":"The hand in mucopolysaccharide disorders","volume":"104","author":"Fisher","year":"1974","journal-title":"Clin Orthop Relat Res"},{"key":"10.1136\/ard.2008.095315_bib16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1302\/0301-620X.79B4.0790576","article-title":"Carpal tunnel syndrome in the mucopolysaccharidoses and mucolipidoses","volume":"79","author":"Haddad","year":"1997","journal-title":"J Bone Joint Surg Br"},{"key":"10.1136\/ard.2008.095315_bib17","first-page":"387","article-title":"Carpal tunnel syndrome in children","volume":"69","author":"Van Meir","year":"2003","journal-title":"Acta Orthop Belg"},{"key":"10.1136\/ard.2008.095315_bib18","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/adc.65.9.962","article-title":"Carpal tunnel syndrome in the mucopolysaccharidoses and related disorders","volume":"65","author":"Wraith","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1136\/ard.2008.095315_bib19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0363-5023(98)80120-2","article-title":"Surgical treatment of carpal tunnel syndrome and trigger digits in children with mucopolysaccharide storage disorders","volume":"23","author":"Van Heest","year":"1998","journal-title":"J Hand Surg [Am]"},{"key":"10.1136\/ard.2008.095315_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01241398-200401000-00019","article-title":"Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation","volume":"24","author":"Weisstein","year":"2004","journal-title":"J Pediatr Orthop"},{"key":"10.1136\/ard.2008.095315_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00006534-197759020-00015","article-title":"Median nerve compression and trigger finger in the mucopolysaccharidoses and related diseases","volume":"59","author":"MacDougal","year":"1977","journal-title":"Plast Reconstr Surg"},{"key":"10.1136\/ard.2008.095315_bib22","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/jnnp.43.12.1148","article-title":"Carpal tunnel syndrome combined with trigger finger in early childhood","volume":"43","author":"Maurer","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1136\/ard.2008.095315_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1442-200X.2003.01654.x","article-title":"Scheie syndrome (MPS-IS) presented as bilateral trigger thumb","volume":"45","author":"Matsui","year":"2003","journal-title":"Pediatr Int"},{"key":"10.1136\/ard.2008.095315_bib24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00003086-199108000-00041","article-title":"Hurler syndrome with special reference to histologic abnormalities of the growth plate","volume":"269","author":"Silveri","year":"1991","journal-title":"Clin Orthop Relat Res"},{"key":"10.1136\/ard.2008.095315_bib25","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/labinvest.3780345","article-title":"Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses","volume":"81","author":"Simonaro","year":"2001","journal-title":"Lab Invest"},{"key":"10.1136\/ard.2008.095315_bib26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"Simonaro","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1136\/ard.2008.095315_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.2008.095315_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/joca.1998.0220","article-title":"Mechanisms of chondrocyte apoptosis","volume":"7","author":"Lotz","year":"1999","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1136\/ard.2008.095315_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C","article-title":"Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes","volume":"44","author":"Tetlow","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.095315_bib30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.59.6.455","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis","volume":"59","author":"Yoshihara","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.095315_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0024-3205(00)00998-X","article-title":"Effects of nitric oxide on matrix metalloproteinase-2 production by rheumatoid synovial cells","volume":"68","author":"Hirai","year":"2001","journal-title":"Life Sci"},{"key":"10.1136\/ard.2008.095315_bib32","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/ard.2006.062463","article-title":"Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage","volume":"66","author":"de Vries-Bouwstra","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.095315_bib33","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.11093","article-title":"Synovial fluid exoglycosidases are predictors of rheumatoid arthritis and are effective in cartilage glycosaminoglycan depletion","volume":"48","author":"Ortutay","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.095315_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1302\/0301-620X.76B6.7983131","article-title":"Bone-marrow transplantation in Hurler\u2019s syndrome. Effect on skeletal development","volume":"76","author":"Field","year":"1994","journal-title":"J Bone Joint Surg Br"},{"key":"10.1136\/ard.2008.095315_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/14656566.6.3.489","article-title":"The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I","volume":"6","author":"Wraith","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1136\/ard.2008.095315_bib36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01241398-199903000-00026","article-title":"Genu valgum deformity in Hurler syndrome after hematopoietic stem cell transplantation: correction by surgical intervention","volume":"19","author":"Odunusi","year":"1999","journal-title":"J Pediatr Orthop"},{"key":"10.1136\/ard.2008.095315_bib37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01241398-199611000-00006","article-title":"Hip dysplasia in Hurler\u2019s syndrome: orthopaedic management after bone marrow transplantation","volume":"16","author":"Masterson","year":"1996","journal-title":"J Pediatr Orthop"},{"key":"10.1136\/ard.2008.095315_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1651-2227.1995.tb13640.x","article-title":"The presenting features of mucopolysaccharidosis type IH (Hurler syndrome)","volume":"84","author":"Cleary","year":"1995","journal-title":"Acta Paediatr"},{"key":"10.1136\/ard.2008.095315_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard.2008.095315_bib40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1136\/ard.2008.095315_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jbspin.2003.10.015","article-title":"Fabry disease: a review","volume":"71","author":"Masson","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1136\/ard.2008.095315_bib42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","article-title":"Narrative review: Fabry disease","volume":"146","author":"Clarke","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.095315_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1399-0004.2005.00457.x","article-title":"Osteopenia and osteoporosis: previously unrecognized manifestations of Fabry disease","volume":"68","author":"Germain","year":"2005","journal-title":"Clin Genet"},{"key":"10.1136\/ard.2008.095315_bib44","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1136\/ard.2008.095315_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00431-003-1362-0","article-title":"Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements","volume":"163","author":"Grabowski","year":"2004","journal-title":"Eur J Pediatr"},{"key":"10.1136\/ard.2008.095315_bib46","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2008.095315_bib47","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpedi.160.6.603","article-title":"The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis","volume":"160","author":"Kaplan","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1136\/ard.2008.095315_bib48","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1136\/ard.2008.095315_bib49","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2106\/00004623-200105000-00016","article-title":"Gaucher disease. New approaches to an ancient disease","volume":"83","author":"Mankin","year":"2001","journal-title":"J Bone Joint Surg Am"},{"key":"10.1136\/ard.2008.095315_bib50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11926-000-0059-x","article-title":"Bone and joint complications related to Gaucher disease","volume":"2","author":"Pastores","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"10.1136\/ard.2008.095315_bib51","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3733","article-title":"Alpha-galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1136\/ard.2008.095315_bib52","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.32.5.498","article-title":"Fabry disease: impaired autonomic function","volume":"32","author":"Cable","year":"1982","journal-title":"Neurology"},{"key":"10.1136\/ard.2008.095315_bib53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0923-1811(98)00032-2","article-title":"The ultrastructural characteristics of eccrine sweat glands in a Fabry disease patient with hypohidrosis","volume":"18","author":"Lao","year":"1998","journal-title":"J Dermatol Sci"},{"key":"10.1136\/ard.2008.095315_bib54","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1136\/ard.2008.095315_bib55","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1136\/ard.2008.095315_bib56","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpeds.2004.01.049","article-title":"Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care","volume":"144","author":"Wilcox","year":"2004","journal-title":"J Pediatr"},{"key":"10.1136\/ard.2008.095315_bib57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J Pediatr"},{"key":"10.1136\/ard.2008.095315_bib58","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.095315_bib59","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1517\/14712598.2.8.967","article-title":"Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I","volume":"2","author":"Brooks","year":"2002","journal-title":"Expert Opin Biol Ther"},{"key":"10.1136\/ard.2008.095315_bib60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10545-006-0490-x","article-title":"Restricted upper extremity range of motion in mucopolysaccharidosis type I: no response to one year of enzyme replacement therapy","volume":"30","author":"Cox-Brinkman","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1136\/ard.2008.095315_bib61","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)","volume":"90","author":"Muenzer","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1136\/ard.2008.095315_bib62","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet Med"},{"key":"10.1136\/ard.2008.095315_bib63","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1136\/ard.2008.095315_bib64","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"Harmatz","year":"2006","journal-title":"J Pediatr"},{"key":"10.1136\/ard.2008.095315_bib65","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jpeds.2004.03.018","article-title":"Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"144","author":"Harmatz","year":"2004","journal-title":"J Pediatr"},{"key":"10.1136\/ard.2008.095315_bib66","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme replacement for lysosomal diseases","volume":"57","author":"Brady","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1136\/ard.2008.095315_bib67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/B:BOLI.0000031101.12838.c6","article-title":"Enzyme replacement and enhancement therapies for lysosomal diseases","volume":"27","author":"Desnick","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1136\/ard.2008.095315_bib68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am J Med"},{"key":"10.1136\/ard.2008.095315_bib69","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2165\/00003495-200767180-00005","article-title":"Treatment of lysosomal storage disorders: progress with enzyme replacement therapy","volume":"67","author":"Rohrbach","year":"2007","journal-title":"Drugs"},{"key":"10.1136\/ard.2008.095315_bib70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-3476(96)70203-2","article-title":"Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase","volume":"129","author":"Kaplan","year":"1996","journal-title":"J Pediatr"},{"key":"10.1136\/ard.2008.095315_bib71","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10545-006-0239-6","article-title":"Limitations of enzyme replacement therapy: current and future","volume":"29","author":"Wraith","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1136\/ard.2008.095315_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2008.095315_bib73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard.2008.095315_bib74","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1073\/pnas.68.2.303","article-title":"Induced degradation of glycosaminoglycans in Hurler\u2019s and Hunter\u2019s syndromes by plasma infusion","volume":"68","author":"Di Ferrante","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2008.095315_bib75","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1073\/pnas.68.8.1738","article-title":"Effect of leukocyte transfusion in a child with type II mucopolysaccharidosis","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2008.095315_bib76","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The clinical outcome of Hurler syndrome after stem cell transplantation","volume":"14","author":"Aldenhoven","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1136\/ard.2008.095315_bib77","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1703839","article-title":"Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines","volume":"31","author":"Peters","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1136\/ard.2008.095315_bib78","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00281-004-0166-2","article-title":"Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases","volume":"26","author":"Krivit","year":"2004","journal-title":"Springer Semin Immunopathol"},{"key":"10.1136\/ard.2008.095315_bib79","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10545-005-0258-8","article-title":"Trends in haematopoietic cell transplantation for inborn errors of metabolism","volume":"29","author":"Boelens","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1136\/ard.2008.095315_bib80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.bmt.1705970","article-title":"Emerging trends in transplantation of inherited metabolic diseases","volume":"41","author":"Prasad","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1136\/ard.2008.095315_bib81","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1007\/s00431-003-1348-y","article-title":"Lysosomal storage disorders: emerging therapeutic options require early diagnosis","volume":"162","author":"Meikle","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1136\/ard.2008.095315_bib82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.20504","article-title":"Guidance on the use of miglustat for treating patients with type 1 Gaucher disease","volume":"80","author":"Weinreb","year":"2005","journal-title":"Am J Hematol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724215855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724215855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2008.095315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:36:31Z","timestamp":1737250591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724215855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":82,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0003496724215855"],"URL":"https:\/\/doi.org\/10.1136\/ard.2008.095315","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Musculoskeletal manifestations of lysosomal storage disorders","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2008.095315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Inc. Publishing Group Ltd and European League Against Rheumatism. All rights reserved. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}